点欠陥の自己組織化的挙動を利用した微細構造形成法

スポンサーリンク

概要

• 論文の詳細を見る
• 日本材料科学会の論文
• 2008-12-20

著者

• 谷脇 雅文

  高知工科大学工学部

• 新田 紀子

  神戸大工

• 新田 紀子

  神戸大学工学研究科機械工学専攻

• TAWARA Masayuki

  Nagasaki CML Study Group

• Takahashi Masatomo

  Division Of Hematology And Oncology Department Of Internal Medicine St. Marianna University School O

• Takahashi Masatomo

  聖マリアンナ医科大学 血液･腫瘍内科

• Matsushima Takafumi

  Department Of Hematology St. Marianna University School Of Medicine

• 谷脇 雅文

  Department Of Environmental Systems Engineering Kochi University Of Technology

• 谷脇 雅文

  高知工科大学

• Tsuchida Masahiro

  産業医科大学 小児科学

• Tanimoto Mitsune

  Okayama Univ. Hospital Okayama Jpn

• Murata Takashi

  Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of

• Tomonaga Masao

  Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi

• Taniwaki M

  Celgene Kk

• Tomonaga Masao

  Department Of Hematology Atomic Bomb Disease Institute Nagasaki University School Of Medicine

• Taniwaki Masafumi

  Third Department Of Internal Medicine Kyoto Prefectural University Of Medicine

• Taniwaki Masafumi

  Department Of Molecular Hematology And Oncology Kyoto Prefectural University Of Medicine Graduate Sc

• Tomonaga Masao

  Department Of Hematology Molecular Medicine Unit Atomic Disease Institute Nagasaki University Gradua

• Tomonaga Masao

  Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University

• Tanimoto Mitsune

  Okayama Univ. Graduate School Of Medicine Okayama Jpn

• Takabayashi Maki

  Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of

関連論文

• 20pHT-4 SiC多形結晶の電子照射誘起構造変化に及ぼす電子励起効果と弾き出し効果(20pHT 格子欠陥,ナノ構造(半導体),領域10(誘電体,格子欠陥,X線・粒子線,フォノン))
• Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
• Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
• Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
• 特集「顕微鏡法による材料開発のための微細構造研究最前線(8)-照射効果の解明と耐照射材料および新素材開発をめざして-」の企画にあたって
• A study of rasburicase for the management of hyperuricemia in pediatric patients with newly diagnosed hematologic malignancies at high risk for tumor lysis syndrome
• イオン注入法によるFe及びCu超微粒子形成とGMR特性(第17回「電磁力関連のダイナミクス」シンポジウム)
• 透過電子顕微鏡法(TEM)の基本原理とその場観察法によるナノ粒子の特異物性解析
• 23aTG-9 C_ナノ粒子における電子励起誘起構造変化(ナノチューブ・グラフェンにおける欠陥,領域7,領域10合同講演,領域7,分子性固体・有機導体)
• 24pYF-11 GaSb, InSbの電子線照射効果(格子欠陥・ナノ構造(半導体),領域10,誘電体,格子欠陥,X線・粒子線,フォノン物性)
• 点欠陥の自己組織化的挙動を利用した微細構造形成法
• イオン照射で導入される点欠陥を利用したナノセル構造の形成
• 半導体の薄膜イオン照射によるボイド形成 (京都大学原子炉実験所第42回学術講演会報文集)
• イオン照射によって導入された点欠陥によるセル構造の形成
• 点欠陥の自己組織化的挙動を利用した新しい微細構造形成法
• イオン照射による半導体微細セル構造の自己組織化形成
• 低温でのSnイオン注入によってGaSb表面に形成される特異な欠陥構造とその形成機構
• Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
• Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
• Surface Sink Effects on Void Formation in GaSb and InSb under Ion Irradiation
• Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
• Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies
• Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
• AuCu合金の相転移と熱膨張挙動
• Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
• Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
• Geographical Study on the Frequency of Epilation among Atomic Bomb Survivors in Nagasaki
• Correlation between Acute Radiation Injuries and Hematological Parameters in Atomic Bomb Survivors
• Mental health conditions among atomic bomb survivors in Nagasaki
• Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
• Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
• Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
• Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Multiple Myeloma : Results from the Japan Myeloma Study Group
• No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
• Case-control study of leukemia and diagnostic radiation exposure
• Outcome of Non-T-Cell-Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation from Family Donors in Children and Adolescents
• Rapid isolation of viral integration site reveals frequent integration of HTLV-1 into expressed loci
• Monosomies 7p and 12p and FLT3 internal tandem duplication : possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution
• Multiple extra-articular synovial cysts complicated with rheumatoid arthritis
• Systemic sclerosis and pseudomesotheliomatous adenocarcinoma of the lung
• Successful cord blood transplantation for mycosis fungoides.
• Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
• Good Prognosis of Patients With Acute Promyelocytic Leukemia Who Achieved Second Complete Remission (CR) With a New Retinoid, Am80, After Relapse From CR Induced by All-trans-Retionic Acid
• The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma : a propensity score matching analysis
• Phase II and pharmacokinetic study of thalidomide in Japanese patients with relapsed/refractory multiple myeloma
• Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
• Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
• Risk of Neutropenic Fever and Early Infectious Complications after Autologous Peripheral Blood Stem Cell Transplantation for Malignant Diseases
• Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes
• Aplastic Anemia
• Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein : a novel in vitro model of the growth of acute ATL cells
• 3 Geographic Effects on Cancer Mortality in Nagasaki A-Bomb Survivors(Atomic bomb effects, Abstracts of the 46th Annual Meeting of the Japan Radiation Research Society)
• A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
• A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
• Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
• Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
• A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma
• Combination Chemotherapy With Risk Factor-Adjusted Dose Attenuation for High-Risk Myelodysplastic Syndrome and Resulting Leukemia in the Multicenter Study of the Japan Adult Leukemia Study Group (JALSG): Results of an Interim Analysis
• Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
• Asymptomatic Patients with Acute Leukemias and Malignant Lymphomas Found in Ningen Dock
• Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
• Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation
• Calcineurin Inhibitor-Induced Irreversible Neuropathic Pain after Allogeneic Hematopoietic Stem Cell Transplantation
• Thrombotic thrombocytopenic purpura associated with myelodysplastic syndrome
• Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-catenin
• IP-1 Confirmation of the Essential Role of LTB4 in Airway Hyperresponsiveness Using LTA4H-Deficient Mice
• Emergence of chronic myelogenous leukemia during treatment for essential thrombocythemia
• Cyclin-dependent kinase inhibitor SU9516 enhances sensitivity to methotrexate in human T-cell leukemia Jurkat cells
• Anti-AnWj antibody in a case with non-Hodgkin lymphoma
• 白滝鉱山が地域にもたらしたもの
• 「わが国の鉱業の過去, 現在そして未来」の企画にあたって
• 小特集の企画にあたって
• Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions
• Expression of heme oxygenase-1 in human leukemic cells and its regulation by transcriptional repressor Bach1
• Cerebral venous sinus thrombosis after allogeneic stem cell transplantation
• Clinical Significance of Fragmented Red Cells after Allogeneic Bone Marrow Transplantation
• Durable Remission by Sobuzoxane in an HIV-Seronegative Patient with Human Herpesvirus 8-Negative Primary Effusion Lymphoma
• A case of systemic lupus erythematosus complicated with pneumatosis cystoides intestinalis
• Use of musculoskeletal ultrasound in Japan : a survey of practicing rheumatologists
• Void Formation and Structure Change Induced by Heavy Ion Irradiation in GaSb and InSb
• Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
• Therapeutic angiogenesis in patients with systemic sclerosis by autologous transplantation of bone-marrow-derived cells
• Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
• Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
• Bortezomib for post-allogeneic hematopoietic stem transplantation relapse and GVHD in multiple myeloma : a single institute experience
• Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
• Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
• Formation of Defect Structure on Ge Surface by Ion Irradiation at Controlled Substrate Temperature
• Pure red cell aplasia caused by parvovirus B19 in two patients without chronic hemolysis
• Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine : a multicenter study
• Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
• Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
• Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
• Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
• Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
• Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
• Intravascular B-cell lymphoma with hypercalcemia as the initial presentation
• Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia : continuity from carrier status to smoldering ATL
• Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma
• Late effect of Atomic bomb radiation on myeloid disorders : leukemia and myelodysplastic syndromes

もっと見る 閉じる

スポンサーリンク